Merck Sharp & Dohme LLC insider trades: Harpoon Therapeutics (HARP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Merck Sharp & Dohme LLC reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | HARP | ↑ Buy | 21,397,205 | $23.00 | $492.1M | Indirect | Mar 11, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Merck Sharp & Dohme LLC's insider trades
Merck Sharp & Dohme LLC is an insider at Harpoon Therapeutics (HARP). Since Mar 11, 2024, it has reported 1 open-market purchase worth $492.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HARP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.